IN8bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.6%.

Top 25 shareholders own 80.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30.7%	Bios Equity Partners LP	7,527,567	€10.9m	0%	no data
17.3%	Emily Fairbairn	4,231,000	€6.1m	22.9%	no data
10.5%	Tai-Wei Ho	2,571,244	€3.7m	1.03%	no data
10.4%	William Ho	2,541,859	€3.7m	0%	no data
4.07%	Steelhead Capital Management, LLC	997,433	€1.4m	0%	no data
1.53%	Voss Capital, LLC	375,570	€544.8k	-25.7%	0.14%
1.17%	Peter Brandt	287,763	€417.4k	57.7%	no data
0.95%	Stonegate Investment Group, LLC	232,310	€337.0k	-12.8%	0.02%
0.69%	The Vanguard Group, Inc.	169,528	€245.9k	53.2%	no data
0.41%	Lawrence Lamb	99,730	€144.7k	0.53%	no data
0.4%	Sigma Planning Corporation	98,750	€143.3k	1.02%	0.01%
0.33%	The Rock Creek Group, LP	81,568	€118.3k	-5.19%	0.01%
0.3%	Bridgeway Capital Management, LLC	74,000	€107.3k	23.3%	no data
0.29%	Ensign Peak Advisors Inc.	70,028	€101.6k	0%	no data
0.23%	Alan Roemer	55,989	€81.2k	88.7%	no data
0.21%	Geode Capital Management, LLC	52,347	€75.9k	489%	no data
0.2%	Precept Capital Management, L.P.	50,000	€72.5k	0%	0.57%
0.095%	BlackRock, Inc.	23,354	€33.9k	-17.9%	no data
0.061%	Warberg Asset Management	15,000	€21.8k	0%	0.06%
0.058%	HighTower Advisors, LLC	14,164	€20.5k	0%	no data
0.057%	United Asset Strategies Inc.	14,000	€20.3k	0%	no data
0.036%	UBS Asset Management	8,724	€12.7k	117%	no data
0.032%	Luba Greenwood	7,826	€11.4k	7.21%	no data
0.021%	Kate Rochlin	5,263	€7.6k	0%	no data
0.021%	Patrick McCall	5,263	€7.6k	0%	no data